Sunday, 1 November 2026European Markets

Central Banking

6 articles

ECB Delays Rate Decision to June as Oil Price Collapse Eases Inflation Pressure

ECB Delays Rate Decision to June as Oil Price Collapse Eases Inflation Pressure

The European Central Bank will postpone interest rate decisions until June following an 11% oil price drop triggered by Iran's reopening of the Strait of Hormuz. ECB policymakers cite high uncertainty over whether the geopolitical shock will produce lasting inflation effects or quickly fade.

LM Salvado•
ECB Signals Potential April Rate Hike as Oil Shock Drives Inflation Concerns

ECB Signals Potential April Rate Hike as Oil Shock Drives Inflation Concerns

The European Central Bank is signaling it cannot rule out raising interest rates as early as April if oil prices remain elevated, according to ECB official Madis Muller. The hawkish pivot comes as geopolitical tensions in the Middle East have pushed crude oil prices up more than 3%, triggering concerns about secondary inflation effects across the eurozone.

LM Salvado•
ECB Signals Possible April Rate Shift as Oil Surge Threatens Inflation Target

ECB Signals Possible April Rate Shift as Oil Surge Threatens Inflation Target

The European Central Bank may adjust interest rates as soon as April if elevated energy prices persist, according to ECB official Madis Muller. The warning comes as oil prices jumped 3% on Middle East tensions, while market expectations for Federal Reserve rate cuts have collapsed from two anticipated cuts in December to a 64% probability of no changes through 2026.

LM Salvado•
ECB Rate Cut Pressure Mounts as Oil Spike to $80 Tests Fed-Europe Monetary Divergence

ECB Rate Cut Pressure Mounts as Oil Spike to $80 Tests Fed-Europe Monetary Divergence

WTI crude surpassing $80 and diesel hitting $4.16 per gallon create conflicting pressures for central banks, with experts calling for ECB rate cuts to counter euro weakness while the Federal Reserve faces renewed inflation risks. Divergent policy frameworks between US and European central banks are emerging as geopolitical tensions—including US-Iran conflicts and Azerbaijan attacks—destabilize energy markets. The Fed's decision to lift Wells Fargo enforcement suggests policy normalization even a

ViaNews Editorial Team (Europe)•
ECB Weighs Rate Cut if Euro Surge Threatens Inflation Target

ECB Weighs Rate Cut if Euro Surge Threatens Inflation Target

The European Central Bank may cut interest rates again if the euro's appreciation significantly lowers inflation projections, according to ECB board member Kocher. The policy consideration comes as Eurozone downside risks ease, creating a complex monetary policy environment for European financial markets.

ViaNews Editorial Team (Europe)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com